Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study

1 Oct 2016

Abstract excerpt

Abstract: Pharmacogenetic testing identifies genetic biomarkers that are predictive of individual sensitivity to particular drugs. A significant proportion of medications that are widely prescribed for older adults are metabolized by enzymes that are encoded by highly polymorphic genes. Pharmacogenetic testing is increasingly used to optimize the medication regimen; however, its potential in older adults with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmaceutical studies and practices

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27789970
DOI: 10.2147/pgpm.s117014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot studyPMID 27789970Read ↗

Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older Adults.Semantic proximity Read ↗

Pharmacogenomic Profiling of Frequently Prescribed Medications Among Geriatric Patients in a Tertiary Care Setting in Southwestern IndiaSemantic proximity Read ↗

Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People.Semantic proximity Read ↗

Prevalence of actionable pharmacogenetic variants and high‐risk drug prescriptions: A Swiss hospital‐based cohort studySemantic proximity Read ↗

Use of pharmacogenomics in elderly patients treated for cardiovascular diseasesSemantic proximity Read ↗

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes.Semantic proximity Read ↗

Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in Veterans.Semantic proximity Read ↗

Genetic Risk Factors for Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenomics in general practice: The time has comeSemantic proximity Read ↗

Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward.Semantic proximity Read ↗

Predicting drug-drug and drug-gene interactions in a community pharmacy population.Semantic proximity Read ↗

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.